6Himmelfarb J,Stenvinkel P,Ikizler TA,et al.The elephant in uremia oxidant stress as a unifying concept of cardiovascular disease in uremia kidney Int,2002,62:1524-1538.
7Boaz M,Smetana S,Weinstein T,et al.Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE):randornised placebo-controlled trial.Lancet,2000,356:1213-1218.
8Tepel M,van der Giet M,Statz M,et al.The antioxidant acetylcysteine reduces cardiovascular events in patients with end stage renal failure:a randomized,controlled trial.Circulation 2003,107:992-995.
9Kay,I.Chow WH,Chan TM,et al.Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention A randomized controlled trial,JAMA,2003,289:553-558.
10Asakimori Y,Yorioka N,Tanaka J,et al.Association between ENOS gene polymorphism and cardiovascular events in nondiabetic hemodialysis patients:a prospective study.American Journal Kidney Disease.2004 Jul;44(1):112-20.
